The authors' response: A diagnostic confusion between serotonin syndrome and neuroleptic malignant syndrome

Am J Emerg Med. 2021 May:43:274. doi: 10.1016/j.ajem.2020.06.048. Epub 2020 Jun 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antipsychotic Agents* / adverse effects
  • COVID-19*
  • Humans
  • Neuroleptic Malignant Syndrome* / diagnosis
  • SARS-CoV-2
  • Serotonin Syndrome* / chemically induced
  • Serotonin Syndrome* / diagnosis

Substances

  • Antipsychotic Agents